We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Nikolai Podoltsev

Nikolai Podoltsev MD, PhD

Associate Professor of Internal Medicine (Hematology); Associate Director of the Hematology/Oncology Fellowship Program, Yale School of Medicine, New Haven, Connecticut
Dr. Nikolai Podoltsev's practice is focused on myeloid neoplasms, including acute myelogenous leukemias (AML), myelodisplastic syndromes (MDS), myeloproliferative neoplasms (MPNs) like polycythemia vera (PV), essential thrombocythemia (ET), myelofibrosis (MF), and chronic myelogenous leukemia (CML), among others. He also provides care for patients with bone marrow failure syndromes/aplastic anemia as well as acute lymphoblastic leukemia. He also follows patients with clonal hematopoiesis of indeterminate potential (CHIP), systemic mastocytosis, and hypereosinophilic syndrome.

Disclosures

Dr. Podoltsev has no relevant disclosures.